However, despite its specificity for prostatic tissue, PSA lacks cancer specificity, as its concentrations can also rise in benign conditions such as benign prostatic hyperplasia (BPH) or prostatitis, thereby limiting its utility as a PCa tumor marker [5], 6]. This evidence concerns the gene KLK3 and benign prostatic hyperplasia.